文献速递胸部技术与安全US

M-BLUE方案评估COVID-19患者:观察者间变异与疾病严重度的相关性

M-BLUE protocol for coronavirus disease-19 (COVID-19) patients: interobserver variability and correlation with disease severity.
PubMed 文献 · Clin Radiol · 2021-02-17

回顾性评估ICU医师与放射科医师使用M-BLUE方案对COVID-19患者行肺超声检查的观察者间变异,并分析总评分与三种疾病严重度评分系统的相关性。

要点

  • M-BLUE方案总评分在ICU医师与放射科医师间观察者间一致性良好(ICC 0.607–0.618)。
  • 不同肺超声征象(0–3分)的观察者间一致性为一般至良好(ICC 0.334–0.601)。
  • 肺超声总评分与三种疾病严重度评分系统呈良好相关(R=0.394–0.660,p<0.01)。

关键影像表现/征象

  • 采用M-BLUE术语描述每侧肺8个不同区域的视频片段肺超声征象并赋对应评分。
  • 不同肺超声征象(0–3分)的观察者间一致性为一般至良好(ICC分别为0.601、0.339、0.334、0.557)。

诊断标准与关键数值

  • M-BLUE方案对每侧肺8个区域进行肺超声检查并赋分,总评分为8个视频片段评分之和。
  • 5名阅片者总体观察者间一致性ICC=0.618,共识意见ICC=0.607。
  • 不同肺超声征象0–3分的观察者间一致性ICC分别为0.601、0.339、0.334、0.557。
  • 肺超声总评分与三种反映疾病严重度的评分系统相关系数R=0.394–0.660(p<0.01)。

临床应用与阅片要点

  • M-BLUE方案可用于COVID-19患者的肺超声评估,不同阅片者间总评分一致性良好。
  • 肺超声总评分可用于提示疾病严重度,与三种疾病严重度评分系统相关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To retrospectively evaluate the interobserver variability of intensive care unit (ICU) practitioners and radiologists who used the M-BLUE (modified bedside lung ultrasound in emergency) protocol to assess coronavirus disease-19 (COVID-19) patients, and to determine the correlation between total M-BLUE protocol score and three different scoring systems reflecting disease severity.

MATERIALS AND METHODS: Institutional review board approval was obtained and informed consent was not required. Ninety-six lung ultrasonography (LUS) examinations were performed using the M-BLUE protocol in 79 consecutive COVID-19 patients. Two ICU practitioners and three radiologists reviewed video clips of the LUS of eight different regions in each lung retrospectively. Each observer, who was blind to the patient information, described each clip with M-BLUE terminology and assigned a corresponding score. Interobserver variability was assessed using intraclass correlation coefficient. Spearman's correlation coefficient analysis (R-value) was used to assess the correlation between the total score of the eight video clips and disease severity.

RESULTS: For different LUS signs, fair to good agreement was obtained (ICC = 0.601, 0.339, 0.334, and 0.557 for 0-3 points respectively). The overall interobserver variability was good for both the five different readers and consensus opinions (ICC = 0.618 and 0.607, respectively). There were good correlations between total LUS score and scores from three systems reflecting disease severity (R=0.394-0.660, p<0.01).

CONCLUSION: In conclusion, interobserver agreement for different signs and total scores in LUS is good and justifies its use in patients with COVID-19. The total scores of LUS are useful to indicate disease severity.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Xue H, Li C, Cui L, et al. M-BLUE protocol for coronavirus disease-19 (COVID-19) patients: interobserver variability and correlation with disease severity. Clin Radiol. 2021. PMID: 33663912. doi:10.1016/j.crad.2021.02.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。